Isolation of stem-like cells from spontaneous feline mammary carcinomas: Phenotypic characterization and tumorigenic potential

Experimental Cell Research

Volumn 318, Issue 7, 2012, Pages 847-860

  Barbieri, Federica ^a   Wurth, Roberto ^a   Ratto, Alessandra ^b   Campanella, Chiara ^b   Vito, Guendalina ^b   Thellung, Stefano ^a   Daga, Antonio ^c   Cilli, Michele ^c   Ferrari, Angelo ^b   Florio, Tullio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b LIGURIA E VALLE D AOSTA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Comparative oncology; Feline; Mammary cancer; Tumor initiating cells

Indexed keywords

CD44V ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CAT DISEASE; CELL CULTURE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CELL ISOLATION; CELL PROLIFERATION; CELL RENEWAL; CELL SIZE; CELL STRUCTURE; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPHEROID CELL; STEM CELL;

FELIDAE; MUS;

EID: 84858277402     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.02.008     Document Type: Article

References (72)

1. Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat. Rev. Cancer 2008, 8:147-156.
2. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 2003, 53:5-26.
3. Hayes A.A., Mooney S. Feline mammary tumors. Vet. Clin. North Am. 1985, 15:513-520.
4. MacEwen E.G. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev. 1990, 9:125-136.
5. Hansen K., Khanna C. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur. J. Cancer 2004, 40:858-880.
6. Vail D.M., MacEwen E.G. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest. 2000, 18:781-792.
7. de las Mulas J.M., van Niel M., Millan Y., Blankenstein M.A., van Mil F., Misdorp W. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest. Anim. Endocrinol. 2000, 18:111-125.
8. Burrai G.P., Mohammed S.I., Miller M.A., Marras V., Pirino S., Addis M.F., Uzzau S., Antuofermo E. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor- and progesterone receptor-negative breast lesions. BMC Cancer 2010, 10:156.
9. Murakami Y., Tateyama S., Rungsipipat A., Uchida K., Yamaguchi R. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. J. Vet. Med. Sci. 2000, 62:743-750.
10. De Maria R., Olivero M., Iussich S., Nakaichi M., Murata T., Biolatti B., Di Renzo M.F. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res. 2005, 65:907-912.
11. Bergkvist G.T., Yool D.A. Epidermal growth factor receptor as a therapeutic target in veterinary oncology. Vet. Comp. Oncol. 2010, 9:81-94.
12. Hermann P.C., Bhaskar S., Cioffi M., Heeschen C. Cancer stem cells in solid tumors. Semin. Cancer Biol. 2011, 20:77-84.
13. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:3983-3988.
14. Collins A.T., Berry P.A., Hyde C., Stower M.J., Maitland N.J. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65:10946-10951.
15. O'Brien C.A., Pollett A., Gallinger S., Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
16. Li C., Heidt D.G., Dalerba P., Burant C.F., Zhang L., Adsay V., Wicha M., Clarke M.F., Simeone D.M. Identification of pancreatic cancer stem cells. Cancer Res. 2007, 67:1030-1037.
17. Singh S., Dwarakanath B.S., Mathew T.L. DNA ligand Hoechst-33342 enhances UV induced cytotoxicity in human glioma cell lines. J. Photochem. Photobiol. 2004, 77:45-54.
18. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
19. Florio T. Adult pituitary stem cells: from pituitary plasticity to adenoma development. Neuroendocrinology 2011, 94:265-277.
20. Stingl J. Detection and analysis of mammary gland stem cells. J. Pathol. 2009, 217:229-241.
21. Ponti D., Costa A., Zaffaroni N., Pratesi G., Petrangolini G., Coradini D., Pilotti S., Pierotti M.A., Daidone M.G. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005, 65:5506-5511.
22. Clarke R.B., Anderson E., Howell A., Potten C.S. Regulation of human breast epithelial stem cells. Cell Prolif. 2003, 36(Suppl 1):45-58.
23. Dontu G., Al-Hajj M., Abdallah W.M., Clarke M.F., Wicha M.S. Stem cells in normal breast development and breast cancer. Cell Prolif. 2003, 36(Suppl 1):59-72.
24. Liao M.J., Zhang C.C., Zhou B., Zimonjic D.B., Mani S.A., Kaba M., Gifford A., Reinhardt F., Popescu N.C., Guo W., Eaton E.N., Lodish H.F., Weinberg R.A. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res. 2007, 67:8131-8138.
25. Phillips T.M., McBride W.H., Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 2006, 98:1777-1785.
26. Li X., Ling V., Li P.C. Same-single-cell analysis for the study of drug efflux modulation of multidrug resistant cells using a microfluidic chip. Anal. Chem. 2008, 80:4095-4102.
27. Fillmore C.M., Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res. 2008, 10:R25.
28. Zoller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?. Nat. Rev. 2011, 11:254-267.
29. Grimshaw M.J., Cooper L., Papazisis K., Coleman J.A., Bohnenkamp H.R., Chiapero-Stanke L., Taylor-Papadimitriou J., Burchell J.M. Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res. 2008, 10:R52.
30. Pang L.Y., Argyle D.J. Using naturally occurring tumours in dogs and cats to study telomerase and cancer stem cell biology. Biochim. Biophys. Acta 2009, 1792:380-391.
31. Cogliati B., Aloia T.P., Bosch R.V., Alves V.A., Hernandez-Blazquez F.J., Dagli M.L. Identification of hepatic stem/progenitor cells in canine hepatocellular and cholangiocellular carcinoma. Vet. Comp. Oncol. 2010, 8:112-121.
32. Matsuzaki P., Cogliati B., Sanches D.S., Chaible L.M., Kimura K.C., Silva T.C., Real-Lima M.A., Hernandez-Blazquez F.J., Laufer-Amorim R., Dagli M.L. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia. J. Comp. Pathol. 2009, 142:84-88.
33. Stoica G., Lungu G., Martini-Stoica H., Waghela S., Levine J., Smith R. Identification of cancer stem cells in dog glioblastoma. Vet. Pathol. 2009, 46:391-406.
34. Nemoto Y., Maruo T., Sato T., Deguchi T., Ito T., Sugiyama H., Ishikawa T., Madarame H., Watanabe T., Shida T., Sahara H. Identification of cancer stem cells derived from a canine lung adenocarcinoma cell line. Vet. Pathol. 2011, 48:1029-1034.
35. Wilson H., Huelsmeyer M., Chun R., Young K.M., Friedrichs K., Argyle D.J. Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet. J. 2008, 175:69-75.
36. Cocola C., Anastasi P., Astigiano S., Piscitelli E., Pelucchi P., Vilardo L., Bertoli G., Beccaglia M., Veronesi M.C., Sanzone S., Barbieri O., Reinbold R.A., Luvoni G.C., Zucchi I. Isolation of canine mammary cells with stem cell properties and tumour-initiating potential. Reprod. Domest. Anim. 2009, 44(Suppl 2):214-217.
37. Michishita M., Akiyoshi R., Yoshimura H., Katsumoto T., Ichikawa H., Ohkusu-Tsukada K., Nakagawa T., Sasaki N., Takahashi K. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines. Res. Vet. Sci. 2011, 91:254-260.
38. Penzo C., Ross M., Muirhead R., Else R., Argyle D.J. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours. Vet. Comp. Oncol. 2009, 7:222-229.
39. Rowell J.L., McCarthy D.O., Alvarez C.E. Dog models of naturally occurring cancer. Trends Mol. Med. 2011, 17:380-388.
40. Porrello A., Cardelli P., Spugnini E.P. Oncology of companion animals as a model for humans. an overview of tumor histotypes. J. Exp. Clin. Cancer Res. 2006, 25:97-105.
41. Nguyen N.P., Almeida F.S., Chi A., Nguyen L.M., Cohen D., Karlsson U., Vinh-Hung V. Molecular biology of breast cancer stem cells: potential clinical applications. Cancer Treat. Rev. 2010, 36:485-491.
42. Misdorp W., Romijn A., Hart A.A. Feline mammary tumors: a case-control study of hormonal factors. Anticancer Res. 1991, 11:1793-1797.
43. Meuten D.J., Calderwood Mays M.B., Dillman R.C., Cooper B.J., Valentine B.A., Kuhajda F.P., Pass D.A. Canine laryngeal rhabdomyoma. Vet. Pathol. 1985, 22:533-539.
44. Florio T., Barbieri F., Spaziante R., Zona G., Hofland L.J., van Koetsveld P.M., Feelders R.A., Stalla G.K., Theodoropoulou M., Culler M.D., Dong J., Taylor J.E., Moreau J.P., Saveanu A., Gunz G., Dufour H., Jaquet P. Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. Endocr. Relat. Cancer 2008, 15:583-596.
45. Griffero F., Daga A., Marubbi D., Capra M.C., Melotti A., Pattarozzi A., Gatti M., Bajetto A., Porcile C., Barbieri F., Favoni R.E., Lo Casto M., Zona G., Spaziante R., Florio T., Corte G. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J. Biol. Chem. 2009, 284:7138-7148.
46. Barbieri F., Bajetto A., Stumm R., Pattarozzi A., Porcile C., Zona G., Dorcaratto A., Ravetti J.L., Minuto F., Spaziante R., Schettini G., Ferone D., Florio T. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas. Clin. Cancer Res. 2008, 14:5022-5032.
47. Barbieri F., Pattarozzi A., Gatti M., Aiello C., Quintero A., Lunardi G., Bajetto A., Ferrari A., Culler M.D., Florio T. Differential Efficacy of Sstr1, 2 and 5 Agonists in the Inhibition of C6 Glioma Growth in Nude Mice. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1078-E1088.
48. Park S.Y., Gonen M., Kim H.J., Michor F., Polyak K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest. 2010, 120:636-644.
49. Tomasson M.H. Cancer stem cells: a guide for skeptics. J. Cell. Biochem. 2009, 106:745-749.
50. Clevers H. The cancer stem cell: premises, promises and challenges. Nat. Med. 2011, 17:313-319.
51. Keller P.J., Lin A.F., Arendt L.M., Klebba I., Jones A.D., Rudnick J.A., Dimeo T.A., Gilmore H., Jefferson D.M., Graham R.A., Naber S.P., Schnitt S., Kuperwasser C. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res. 2010, 12:R87.
52. Charafe-Jauffret E., Ginestier C., Iovino F., Wicinski J., Cervera N., Finetti P., Hur M.H., Diebel M.E., Monville F., Dutcher J., Brown M., Viens P., Xerri L., Bertucci F., Stassi G., Dontu G., Birnbaum D., Wicha M.S. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009, 69:1302-1313.
53. Munson L., Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast Dis. 2007, 28:7-21.
54. Blacking T.M., Waterfall M., Argyle D.J. CD44 is associated with proliferation, rather than a specific cancer stem cell population, in cultured canine cancer cells. Vet. Immunol. Immunopathol. 2011, 141:46-57.
55. Sorenmo K.U., Rasotto R., Zappulli V., Goldschmidt M.H. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Vet. Pathol. 2011, 48:85-97.
56. Dey D., Saxena M., Paranjape A.N., Krishnan V., Giraddi R., Kumar M.V., Mukherjee G., Rangarajan A. Phenotypic and functional characterization of human mammary stem/progenitor cells in long term culture. PLoS One 2009, 4:e5329.
57. Lawson J.C., Blatch G.L., Edkins A.L. Cancer stem cells in breast cancer and metastasis. Breast Cancer Res. Treat. 2009, 118:241-254.
58. Zhao X., Malhotra G.K., Lele S.M., Lele M.S., West W.W., Eudy J.D., Band H., Band V. Telomerase-immortalized human mammary stem/progenitor cells with ability to self-renew and differentiate. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14146-14151.
59. Dittmer A., Schunke D., Dittmer J. PTHrP promotes homotypic aggregation of breast cancer cells in three-dimensional cultures. Cancer Lett. 2008, 260:56-61.
60. Rappa G., Lorico A. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line. Exp. Cell Res. 2010, 316:1576-1586.
61. Gama A., Gartner F., Alves A., Schmitt F. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues. Res. Vet. Sci. 2009, 87:432-437.
62. Minke J.M., Schuuring E., van den Berghe R., Stolwijk J.A., Boonstra J., Cornelisse C., Hilkens J., Misdorp W. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors. Cancer Res. 1991, 51:4028-4037.
63. Li C., Iida M., Dunn E.F., Ghia A.J., Wheeler D.L. Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene 2009, 28:3801-3813.
64. Wiley H.S. Trafficking of the ErbB receptors and its influence on signaling. Exp. Cell Res. 2003, 284:78-88.
65. Lo H.W., Hsu S.C., Hung M.C. EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization. Breast Cancer Res. Treat. 2006, 95:211-218.
66. Lo H.W., Xia W., Wei Y., Ali-Seyed M., Huang S.F., Hung M.C. Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer. Cancer Res. 2005, 65:338-348.
67. Normanno N., De Luca A., Carotenuto P., Lamura L., Oliva I., D'Alessio A. Prognostic applications of gene expression signatures in breast cancer. Oncology 2009, 77(Suppl 1):2-8.
68. Millanta F., Calandrella M., Vannozzi I., Poli A. Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance. Vet. Rec. 2006, 158:821-824.
69. Farnie G., Clarke R.B. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev. 2007, 3:169-175.
70. Shipitsin M., Campbell L.L., Argani P., Weremowicz S., Bloushtain-Qimron N., Yao J., Nikolskaya T., Serebryiskaya T., Beroukhim R., Hu M., Halushka M.K., Sukumar S., Parker L.M., Anderson K.S., Harris L.N., Garber J.E., Richardson A.L., Schnitt S.J., Nikolsky Y., Gelman R.S., Polyak K. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007, 11:259-273.
71. Clarke R.B., Spence K., Anderson E., Howell A., Okano H., Potten C.S. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev. Biol. 2005, 277:443-456.
72. Jung J.W., Park S.B., Lee S.J., Seo M.S., Trosko J.E., Kang K.S. Metformin represses self-renewal of the human breast carcinoma stem cells via inhibition of estrogen receptor-mediated OCT4 expression. PLoS One 2011, 6:e28068.